This formulation presents the major hyaluronic acid concentration of Rjdephyne lines (26 MG/ML) and the highest elasto-plasticity properties. It is indicated to increase the volumes and redefinition of the oval face shape, facial lipoatrophy, chin, and mandibular area with a recommended injection in the deep dermis or shallow subcutaneous tissue.
Technical features
Gel Type: Monophasic Gel
HA content: 26 mg/mi
Cross-linked agent: BDDE
Dosage: 1 ml
Needle size: 25G Needles
Bacterial Endotoxin: <0.5Eu/mg
Duration: 8-18 months
Certificates: CE 0373, ISO 13485
Where to inject: Deep dermis or shallow subcutaneous tissue
